The confidentiality of the information contained in the administrative file of a fixed-dose combination medicinal product and the need for an opinion on relevance in order to lift such level of protection
[et_pb_section bb_built=”1″ _builder_version=”3.19.5″][et_pb_row][et_pb_column type=”2_5″][et_pb_image _builder_version=”3.19.5″ src=”https://vidalquadrasramon.com/wp-content/uploads/2021/02/VQR_LAW_NEW34.jpg” /][/et_pb_column][et_pb_column type=”3_5″][et_pb_post_title _builder_version=”3.19.5″ comments=”off” featured_image=”off” /][et_pb_text _builder_version=”3.19.5″] In some recent and interesting …
VIDAL-QUADRAS & RAMON EXPANDS ITS TEAM AND STRENGTHENS THE TRADEMARK AREA
[et_pb_section bb_built=”1″ _builder_version=”3.19.5″][et_pb_row][et_pb_column type=”2_5″][et_pb_image _builder_version=”3.19.5″ src=”https://vidalquadrasramon.com/wp-content/uploads/2021/02/VQR-socios-vqr.jpg” /][/et_pb_column][et_pb_column type=”3_5″][et_pb_post_title _builder_version=”3.19.5″ comments=”off” featured_image=”off” /][et_pb_text _builder_version=”3.19.5″] Vidal-Quadras & Ramon has expanded …
INSIGHTS
Patents, Patents
Sorafenib: a divergent case, like so many others
General, Trademarks
